Contact Information:
Kim Kelley
kim_kelley@eisai.com
763-232-2475

Amy Flynn Brennan
amyflynn_brennan@eisai.com
320-249-1677

To connect with these representatives during conference breaks, click here:
https://eisai.zoom.us/j/98576078467?pwd=dDVHbytQLzVqRXE4OFNHbmVDZjdPZz09

Meeting ID: 985 7607 8467
Passcode: 594990

Virtual Exhibit Hall Home

At Eisai Inc., human health care (hhc) is our goal. We give our first thoughts to patients and their families, and helping to increase the benefits health care provides. As the U.S. pharmaceutical subsidiary of Tokyo-based Eisai Co., Ltd., we have a passionate commitment to patient care that is the driving force behind our efforts to discover and develop innovative therapies to help address unmet medical needs.

Eisai is a fully integrated pharmaceutical business that operates in two global business groups: oncology and neurology (dementia-related diseases and neurodegenerative diseases). Our U.S. headquarters, commercial and clinical development organizations are located in New Jersey; our discovery labs are in Massachusetts and Pennsylvania; and our global demand chain organization resides in Maryland and North Carolina. To learn more about Eisai Inc., please visit us at www.eisai.com/US and follow us on Twitter and LinkedIn.